Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients with or without Comorbid Vascular Disease: Insights from the GARFIELD-AF Registry

Many patients with atrial fibrillation suffer from comorbid vascular disease. The comparative efficacy and safety of different types of oral anticoagulation (OAC) in this patient group have not been widely studied.

Source: The American Journal of Medicine - September 11, 2023 Category: General Medicine Authors: Freek W.A. Verheugt, Keith A.A. Fox, Saverio Virdone, Giuseppe Ambrosio, Bernard J. Gersh, Sylvia Haas, Karen S. Pieper, Gloria Kayani, A. John Camm, Alexandr Parkhomenko, Frank Misselwitz, APHany Ragy, Hugo ten Cate, Matyas Keltai, Ajay K. Kakkar, GARFIE Tags: Clinical Research Study Source Type: research